Vericel (VCEL) Non-Current Assets (2010 - 2026)

Vericel (VCEL) reported Non-Current Assets of $241.6 million for Q1 2026, up 6.44% on a YoY basis from $226.9 million in Q1 2025, and little changed sequentially from $240.5 million in Q4 2025.

Vericel (VCEL) Non-Current Assets (2010 - 2026) Analysis & Trends

Vericel (VCEL) has 17 years of Non-Current Assets data on file, last reported at $241.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets rose 6.44% year-over-year to $241.6 million; the trailing twelve-month figure through Mar 2026 stood at $944.4 million (up 14.31% YoY), and the FY2025 full-year result was $240.5 million, up 9.36% from the prior year.
  • Non-Current Assets held at $241.6 million in Q1 2026, from $240.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $241.6 million in Q1 2026 to a low of $81.6 million in Q3 2022.
  • A 5-year average of $163.5 million and a median of $166.9 million in 2024 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets fell 0.97% in 2023 and soared 90.68% in 2024, its largest moves.
  • Tracing VCEL's Non-Current Assets over 5 years: stood at $86.1 million in 2022, then surged by 71.85% to $148.0 million in 2023, then soared by 48.59% to $219.9 million in 2024, then increased by 9.36% to $240.5 million in 2025, then increased by 0.43% to $241.6 million in 2026.
  • Business Quant data shows VCEL's Non-Current Assets at $241.6 million in Q1 2026, $240.5 million in Q4 2025, and $231.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn 241.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 241.56 Mn
Dec 31, 2025 240.53 Mn
Sep 30, 2025 231.31 Mn
Jun 30, 2025 231.03 Mn
Mar 31, 2025 226.95 Mn
Dec 31, 2024 219.95 Mn
Sep 30, 2024 199.89 Mn
Jun 30, 2024 179.45 Mn
Mar 31, 2024 166.94 Mn
Dec 31, 2023 148.03 Mn
Sep 30, 2023 131.91 Mn
Jun 30, 2023 127.84 Mn
Mar 31, 2023 87.55 Mn
Dec 31, 2022 86.14 Mn
Sep 30, 2022 81.64 Mn
Jun 30, 2022 89.72 Mn
Mar 31, 2022 88.41 Mn
Dec 31, 2021 85.24 Mn
Sep 30, 2021 79.20 Mn
Jun 30, 2021 83.43 Mn